WBDE

Version ORCA: PHTS 1.21.1 (Released July 16th, 2026)

Form 18: Donor Derived Cell Free DNA

  • Question 3: Reworded to say, ‘within 30 days’

Form 1T: Transplant

  • Question 6b: Reworded to say, ‘location at the time of organ acceptance?’

Form 8: Post Transplant Follow up

  • Added new medication under Cardiovascular Medications: SGLT2 inhibitors (dapagliflozin and empagliflozin)
  • Added new question: ‘How long did patient receive pneumocystis prophylaxis?’
  • Added new question: ‘With which agent(s)? Select all that apply’
  • Added new question: ‘Was prophylaxis prematurely discontinued or modified?’

Form 3: Initial Immunosuppression and Antibiotics

  • Added question: ‘How long do you intend to use pneumocystis prophylaxis?’